Growth Metrics

Albemarle (ALB) EBIAT (2016 - 2025)

Albemarle (ALB) has disclosed EBIAT for 17 consecutive years, with -$600.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIAT fell 268.44% year-over-year to -$600.3 million, compared with a TTM value of -$806.3 million through Dec 2025, up 56.44%, and an annual FY2025 reading of -$709.0 million, up 61.7% over the prior year.
  • EBIAT was -$600.3 million for Q4 2025 at Albemarle, down from -$147.9 million in the prior quarter.
  • Across five years, EBIAT topped out at $1.3 billion in Q1 2023 and bottomed at -$1.1 billion in Q3 2024.
  • Average EBIAT over 5 years is -$34.8 million, with a median of -$54.4 million recorded in 2021.
  • The sharpest move saw EBIAT surged 353.46% in 2023, then plummeted 559.62% in 2024.
  • Year by year, EBIAT stood at -$65.8 million in 2021, then skyrocketed by 1463.53% to $897.2 million in 2022, then plummeted by 178.06% to -$700.4 million in 2023, then skyrocketed by 76.73% to -$162.9 million in 2024, then plummeted by 268.44% to -$600.3 million in 2025.
  • Business Quant data shows EBIAT for ALB at -$600.3 million in Q4 2025, -$147.9 million in Q3 2025, and -$43.1 million in Q2 2025.